Novo Nordisk A/S (NVO)
45.60
-0.66
(-1.42%)
USD |
NYSE |
Aug 28, 16:00
45.57
-0.04
(-0.08%)
After-Hours: 20:00
Novo Nordisk Total Return Price : 45.60 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 46.26 |
| August 26, 2026 | 47.19 |
| August 25, 2026 | 48.66 |
| August 24, 2026 | 46.92 |
| August 21, 2026 | 46.74 |
| August 20, 2026 | 46.14 |
| August 19, 2026 | 46.48 |
| August 18, 2026 | 45.71 |
| August 17, 2026 | 44.88 |
| August 14, 2026 | 45.31 |
| August 13, 2026 | 46.13 |
| August 12, 2026 | 45.81 |
| August 11, 2026 | 46.58 |
| August 10, 2026 | 47.13 |
| August 07, 2026 | 46.66 |
| August 06, 2026 | 45.39 |
| August 05, 2026 | 43.97 |
| August 04, 2026 | 43.72 |
| August 03, 2026 | 46.50 |
| July 31, 2026 | 46.49 |
| July 30, 2026 | 50.96 |
| July 29, 2026 | 50.93 |
| July 28, 2026 | 50.32 |
| July 27, 2026 | 49.04 |
| July 24, 2026 | 48.16 |
| Date | Value |
|---|---|
| July 23, 2026 | 47.57 |
| July 22, 2026 | 47.58 |
| July 21, 2026 | 48.76 |
| July 20, 2026 | 48.98 |
| July 17, 2026 | 49.69 |
| July 16, 2026 | 50.83 |
| July 15, 2026 | 49.92 |
| July 14, 2026 | 48.45 |
| July 13, 2026 | 48.66 |
| July 10, 2026 | 48.86 |
| July 09, 2026 | 48.26 |
| July 08, 2026 | 48.27 |
| July 07, 2026 | 49.01 |
| July 06, 2026 | 48.64 |
| July 02, 2026 | 49.79 |
| July 01, 2026 | 48.16 |
| June 30, 2026 | 47.34 |
| June 29, 2026 | 47.73 |
| June 26, 2026 | 47.46 |
| June 25, 2026 | 47.04 |
| June 24, 2026 | 46.81 |
| June 23, 2026 | 46.82 |
| June 22, 2026 | 45.30 |
| June 18, 2026 | 42.65 |
| June 17, 2026 | 42.97 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AstraZeneca PLC | 162.67 |
| Johnson & Johnson | 268.05 |
| Eli Lilly & Co. | 1173.92 |
| Merck & Co., Inc. | 148.30 |
| Novartis AG | 153.79 |